Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

NCT00751517 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Wegener's Granulomatosis
Churg-Strauss Syndrome
Microscopic Polyangiitis
Polyarteritis Nodosa

Interventions

DRUG: Methotrexate
DRUG: Cyclophosphamide

Sponsor

University of Parma